On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

-The Hindu “The current version of the text added new burdensome conditions that would impose additional limits on countries using non-voluntary licensing” Six experts from India, South Africa and the United States have written to Prime Minister Narendra Modi to reject the current version of a proposal at the world trade organisation on intellectual property waivers for COVID-19 medicines, that includes vaccines, drugs and diagnostics. In October 2020, at the WTO’s Trade Related...

-The Hindu Negotiations are at a “critical and sensitive” stage in Geneva, say sources India runs the risk of being excluded from a proposal it co-authored at the world trade organisation (WTO) negotiations, in 2020, to “temporarily waive” intellectual property rights (IPR) held, by primarily Western countries, on vaccines, therapeutics and diagnostics for covid-19. Geneva Health Files, a Switzerland-based newsletter portal that tracks developments in intellectual property, first reported on Friday that “a...

-The Hindu An upbeat global trade scenario provides an ideal setting for Trade Ministers to correct iniquitous rules and provisions The World Trade Organization (WTO)’s 12th Ministerial Conference (MC12) is being convened in Geneva, Switzerland at the end of this month, a year-and-a-half after it was scheduled to be held in Kazakhstan (June 2020, but postponed due to the novel coronavirus pandemic). The MC12 is being held at an important juncture when...

-Newsclick.in It appears the stage is being set to scuttle India and South Africa’s IP waiver proposal with regard to Covid vaccines and technology ahead of the 12th WTO Ministerial this month-end. At various global fora, Big Pharma and rich countries have been steadfastly pushing the focus toward supply-side bottlenecks of vaccines and unequal distribution of doses in a bid to steer the discourse away from the more contentious issue of patents...